Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-05 Sale | 2024-03-07 1:27 pm | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 1,893 | $74.3 | $140,650 | 29,345 (Direct) | View |
2024-02-28 Sale | 2024-02-29 6:50 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 140 | $88.46 | $12,384 | 71,225 (Direct) | View |
2023-09-22 Purchase | 2023-09-25 4:44 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER | 4,000 | $59.38 | $237,529 | 73,090 (Direct) | View |
2023-05-16 Sale | 2023-05-18 5:18 pm | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 4,444 | $77.2 | $343,081 | 38,488 (Direct) | View |
2023-05-10 Sale | 2023-05-12 3:43 pm | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 6,408 | $77.13 | $494,225 | 26,711 (Direct) | View |
2023-05-08 Sale | 2023-05-10 7:15 pm | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 6,408 | $76.56 | $490,628 | 42,213 (Direct) | View |
2023-03-24 Sale | 2023-03-28 5:00 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks | 300 | $69.92 | $20,977 | 16,308 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,156 | $68.51 | 120,160 (Direct) | View |
2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 7,448 | $46.2 | 120,160 (Direct) | View |
2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 3,556 | $66.19 | 120,160 (Direct) | View |
2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A 2032-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 16,015 | $0 | 120,160 (Direct) | View |
2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,855 | $67.24 | 120,160 (Direct) | View |
2024-03-05 Exercise | 2024-03-07 1:27 pm | N/A 2024-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,893 | $0 | 29,345 (Direct) | View |
2024-03-05 Exercise | 2024-03-06 5:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 2,893 | $39.35 | 131,041 (Direct) | View |
2024-03-05 Exercise | 2024-03-06 5:28 pm | N/A 2024-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 2,893 | $0 | 131,041 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 6:50 pm | N/A 2034-02-27 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & | 36,480 | $0 | 51,477 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 6:50 pm | N/A 2034-02-27 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 72,960 | $0 | 162,405 (Direct) | View |
2024-02-28 Exercise | 2024-02-29 6:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 799 | $55.75 | 71,225 (Direct) | View |
2024-02-28 Exercise | 2024-02-29 6:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 325 | $58.49 | 71,225 (Direct) | View |
2024-02-28 Exercise | 2024-02-29 6:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 140 | $57.22 | 71,225 (Direct) | View |
2024-02-28 Exercise | 2024-02-29 6:50 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,264 | $0 | 71,225 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 6:50 pm | N/A 2034-02-27 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 36,480 | $0 | 71,225 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 6:49 pm | N/A 2034-02-27 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER | 164,159 | $0 | 235,868 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 8:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & | 593 | $74.65 | 14,997 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 8:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 4,778 | $74.65 | 89,445 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 8:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,479 | $74.65 | 21,423 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 8:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER | 1,381 | $74.65 | 71,709 (Direct) | View |
2023-12-29 Other | 2024-01-04 4:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & | 179 | $60.71 | 15,769 (Direct) | View |
2024-01-02 Tax Withholding | 2024-01-04 4:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 2,917 | $72.31 | 94,223 (Direct) | View |
2023-12-05 Tax Withholding | 2023-12-06 3:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,269 | $59.61 | 22,902 (Direct) | View |
2023-12-05 Tax Withholding | 2023-12-06 3:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 1,984 | $59.61 | 97,140 (Direct) | View |
2023-10-01 Tax Withholding | 2023-10-03 4:36 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 346 | $59.92 | 24,171 (Direct) | View |
2023-09-22 Option Award | 2023-09-26 4:41 pm | N/A 2033-09-22 | LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director | 13,630 | $0 | 13,630 (Direct) | View |
2023-08-10 Tax Withholding | 2023-08-14 4:20 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & | 897 | $68.73 | 15,411 (Direct) | View |
2023-06-30 Other | 2023-07-10 6:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | 376 | $56.78 | 99,500 (Direct) | View |
2023-06-30 Other | 2023-07-10 6:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 375 | $56.78 | 24,892 (Direct) | View |
2023-06-09 Option Award | 2023-06-21 09:28 am | N/A 2033-06-09 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 6,603 | $0 | 32,387 (Direct) | View |
2023-06-09 Option Award | 2023-06-13 6:55 pm | N/A 2033-06-09 | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 6,603 | $0 | 12,028 (Direct) | View |
2023-06-09 Option Award | 2023-06-13 6:55 pm | N/A 2033-06-09 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 6,603 | $0 | 33,724 (Direct) | View |
2023-06-09 Option Award | 2023-06-13 6:54 pm | N/A 2033-06-09 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 6,603 | $0 | 45,091 (Direct) | View |
2023-06-09 Option Award | 2023-06-13 6:54 pm | N/A 2033-06-09 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 6,603 | $0 | 133,609 (Direct) | View |
2023-06-09 Option Award | 2023-06-13 6:53 pm | N/A 2033-06-09 | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 6,603 | $0 | 9,606 (Direct) | View |
2023-06-09 Tax Withholding | 2023-06-13 6:52 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER | 420 | $73.76 | 69,090 (Direct) | View |
2023-05-10 Exercise | 2023-05-12 3:43 pm | N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 6,408 | $0 | 26,711 (Direct) | View |
2023-05-08 Exercise | 2023-05-10 7:15 pm | N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 6,408 | $0 | 42,213 (Direct) | View |
2023-05-08 Exercise | 2023-05-10 7:15 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 6,408 | $18.82 | 42,213 (Direct) | View |
2023-02-23 Option Award | 2023-02-27 8:54 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 22,465 | $0 | 40,561 (Direct) | View |
2023-02-23 Option Award | 2023-02-27 8:52 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 33,697 | $0 | 123,376 (Direct) | View |
2023-02-23 Option Award | 2023-02-27 8:51 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks | 21,061 | $0 | 32,001 (Direct) | View |
2023-02-23 Option Award | 2023-02-27 8:50 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 63,183 | $0 | 114,969 (Direct) | View |
2023-02-15 Tax Withholding | 2023-02-17 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 2,890 | $72.98 | 89,679 (Direct) | View |
2023-02-15 Tax Withholding | 2023-02-17 7:20 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 849 | $72.98 | 18,096 (Direct) | View |
2022-12-30 Other | 2023-01-04 5:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 275 | $56.78 | 19,220 (Direct) | View |